Outset Medical Inc
For the period ended Dec 31, 2023. Filed Feb 21, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 21, 2024
OM$4.12-2.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
Exhibit Index
| Incorporation by Reference | |||||
|---|---|---|---|---|---|
| ExhibitNumber | Description | Form | File No. | Exhibit | Filing Date |
| 3.1 | Form of Amended and Restated Certificate of Incorporation of Outset Medical, Inc. | S-1/A | 333-248225 | 3.1 | September 9, 2020 |
| 3.2 | Form of Amended and Restated Bylaws of Outset Medical, Inc. | S-1/A | 333-248225 | 3.2 | September 9, 2020 |
| 4.1 | Form of Common Stock Certificate | S-1/A | 333-248225 | 4.1 | September 9, 2020 |
| 4.2 | Amended and Restated Registration Rights Agreement | S-1 | 333-248225 | 4.2 | August 21, 2020 |
| 4.3 | Form of Series A Warrant Agreement #1 | S-1 | 333-248225 | 4.3 | August 21, 2020 |
| 4.4 | Form of Series A Warrant Agreement #2 | S-1 | 333-248225 | 4.4 | August 21, 2020 |
| 4.5 | Description of Outset Medical, Inc.’s Securities Registered Pursuant to Section 12 of the Exchange Act | 10-K | 001-39513 | 4.5 | March 22, 2021 |
| 10.1† | Form of Indemnification Agreement | S-1/A | 333-248225 | 10.1 | September 9, 2020 |
| 10.2† | Outset Medical, Inc. 2010 Equity Incentive Plan and related form agreements | S-1 | 333-248225 | 10.2 | August 21, 2020 |
| 10.3† | Outset Medical, Inc. 2019 Equity Incentive Plan and related form agreements | S-1 | 333-248225 | 10.3 | August 21, 2020 |
| 10.4†* | Outset Medical, Inc. 2020 Equity Incentive Plan, as amended and restated | ||||
| 10.5† | Form of Stock Option Grant Notice and Option Agreement for Outset Medical, Inc. 2020 Equity Incentive Plan | 10-K | 001-39513 | 10.5 | March 22, 2021 |
| 10.6† | Form of Restricted Stock Unit Award Grant Notice and Award Agreement for Outset Medical, Inc. 2020 Equity Incentive Plan | 10-K | 001-39513 | 10.6 | March 22, 2021 |
| 10.7† | Form of Restricted Stock Award Grant Notice and Award Agreement for Outset Medical, Inc. 2020 Equity Incentive Plan | 10-K | 001-39513 | 10.7 | March 22, 2021 |
| 10.8† | Form of Performance Stock Unit Award Grant Notice and Award Agreement for Outset Medical, Inc. 2020 Equity Incentive Plan | 10-K | 001-39513 | 10.8 | March 22, 2021 |
| 10.9† | Outset Medical, Inc. Employee Stock Purchase Plan, as amended and restated | 10-Q | 001-39513 | 10.3 | November 9, 2022 |
| 10.10† | Employment Agreement by and between Outset Medical and Leslie Trigg, dated as of February 23, 2015 | S-1 | 333-248225 | 10.6 | August 21, 2020 |
| 10.11* | Form of Amended and Restated Change in Control and Severance Agreement for Chief Executive Officer | ||||
| 10.12* | Form of Amended and Restated Change in Control and Severance Agreement for non-Chief Executive Officer executive officers | ||||
| 10.13# | Lease by and between WH Silicon Valley IV LP and Outset Medical, Inc., dated as of September 19, 2019 | S-1 | 333-248225 | 10.10 | August 21, 2020 |
| 10.14# | Sublease Agreement by and among Inmobiliaria IAMSA, S.A. de C.V. (Sublessor), Baja Fur S.A. de C.V. (Sublessee) and Outset Medical, Inc. (Guarantor), dated as of May 5, 2020 | S-1 | 333-248225 | 10.11 | August 21, 2020 |
| 10.15# | First Amendment Agreement by and among Inmobiliaria IAMSA, S.A. de C.V. (Sublessor), Baja Fur S.A. de C.V. (Sublessee) and Outset Medical, Inc. (Guarantor), dated as of June 26, 2020 | S-1 | 333-248225 | 10.12 | August 21, 2020 |
| 10.16# | Guaranty by and between Inmobiliaria IAMSA, S.A. de C.V. and Outset Medical, Inc dated as of May 6, 2020 | S-1 | 333-248225 | 10.13 | August 21, 2020 |
| 10.17# | Manufacturing Services Agreement by and between TACNA Services, Inc. and Outset Medical, Inc. dated as of January 15, 2020 | S-1 | 333-248225 | 10.17 | August 21, 2020 |
| 10.18# | Authorized Reseller Agreement by and between SDV Office Systems, LLC dba SDV Medical and Outset Medical, Inc. dated as of October 14, 2019 | S-1 | 333-248225 | 10.18 | August 21, 2020 |
| 10.19# | Amendment 1 to the Authorized Reseller Agreement by and between SDV Office Systems, LLC dba SDV Medical and Outset Medical, Inc. dated as of March 26, 2020 | S-1 | 333-248225 | 10.19 | August 21, 2020 |
| 10.20# | Amendment 2 to the Authorized Reseller Agreement by and between SDV Office Systems, LLC dba SDV Medical and Outset Medical, Inc. dated as of May 6, 2020 | S-1 | 333-248225 | 10.20 | August 21, 2020 |
| 10.21# | Purchasing Agreement by and between HCA Management Services, L.P. and Outset Medical, Inc. dated as of May 1, 2020 | S-1 | 333-248225 | 10.21 | August 21, 2020 |
| 10.22# | Supply Agreement by and between Carlisle Interconnect Technologies, Inc. and Outset Medical, Inc., dated January 12, 2021 | 10-K | 001-39513 | 10.30 | March 22, 2021 |
| 10.22 | Loan and Security Agreement by and between SLR Investment Corp., the lenders from time to time party thereto and Outset Medical, Inc. dated as of November 3, 2022 | 10-Q | 001-39513 | 10.1 | November 9, 2022 |
| 10.24 | Credit Agreement by and between Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL and Outset Medical, Inc. dated as of November 3, 2022 | 10-Q | 001-39513 | 10.2 | November 9, 2022 |
| 10.25* | First Amendment to Loan and Security Agreement by and among SLR Investment Corp., as collateral agent, the lenders party thereto and Outset Medical, Inc. dated as of December 11, 2023 | ||||
| 23.1* | Consent of KPMG LLP, independent registered public accounting firm | ||||
| 24.1* | Power of Attorney (included on the signature page) | ||||
| 31.1* | Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | ||||
| 31.2* | Certification of Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | ||||
| 32.1* | Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | ||||
| 97.1* | Outset Medical, Inc. Policy on Recoupment of Incentive Compensation | ||||
| 101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema with Embedded Linkbase Documents | ||||
| 104 | Cover Page formatted as inline XBRL and contained in Exhibits 101 | ||||
- Filed herewith
† Indicates a management contract or compensatory plan or arrangement.
Portions of the exhibit have been or will be excluded because it is both not material and is the type of information that the registrant treats as private or confidential.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.